STREAM MDR-TB Trial recruits 400th Patient
28 April 2015
Professor Andrew Nunn, associate director of the MCR Clinical Trials Unit, was pleased to tell us that STREAM has reached its target for Stage 1.
Patients have been recruited from three sites in South Africa, two in Ethiopia, one in Vietnam and one in Mongolia. The plan is to continue to enrol for a few more weeks to ensure sufficient assessable participants are available for the primary 30 month analysis. In the meantime the Stage 2 protocol, which includes two new short-course regimens has been finalised and the process of obtaining the necessary permissions to begin enrolment has commenced.
STREAM trial is funded by USAID and MRC and sponsored by the International Union Against TB and Lung Disease.